Fiche centre
Tampere University Hospital
Tampere — Finland
Essais liés5clinical trials
VilleTamperelocalisation
PaysFinlandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03436485
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Giredestrant | Cancer | Phase 3 | NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) | ACTIVE_NOT_RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| ODM-208 | Cancer | Phase 1/2 | NCT03436485 | CYPIDES — Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer | ACTIVE_NOT_RECRUITING |
| InNIVALS — Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency | Sclérose latérale amyotrophique | Non applicable | NCT06286917 | InNIVALS — Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency | ACTIVE_NOT_RECRUITING |
| Limb salvage | Myopathies | À vérifier | NCT02380651 | Functional Outcomes and HRQoL in Upper-extremity Sarcoma Patients After Limb Salvage | COMPLETED |